Line 18:
Line 18:
== Resources from the international guideline community ==
== Resources from the international guideline community ==
−
=== Example disclosure of interest forms: ===
+
=== Examples of disclosure of interest forms: ===
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i12 American Thoracic Society disclosure of interests form]
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i12 American Thoracic Society disclosure of interests form]
−
* CADTH pan-Canadian Oncology Drug Review disclosure of interest form for panel members
+
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-coi-guidelines-form.docx CADTH pan-Canadian Oncology Drug Review disclosure of interest form for panel members]
−
* CADTH pan-Canadian Oncology Drug Review disclosure of interest form for clinicians
+
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-clinician_coi-declaration.docx CADTH pan-Canadian Oncology Drug Review disclosure of interest form for clinicians]
−
* CADTH pan-Canadian Oncology Drug Review disclosure of interest form for patient groups
+
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-patientad-coi-declaratio.doc CADTH pan-Canadian Oncology Drug Review disclosure of interest form for patient groups]
−
* Canadian Task Force on Preventive Healthcare disclosure of interest form (see Appendix 1)
+
* [https://canadiantaskforce.ca/wp-content/uploads/2016/12/procedural-manual-en_2014_Archived.pdf Canadian Task Force on Preventive Healthcare disclosure of interest form] (see Appendix 1)
−
* Cochrane Collaboration disclosure of interest form
+
* [https://community.cochrane.org/sites/default/files/uploads/EPPR/Cochrane-COI-disclosure-form.pdf Cochrane Collaboration disclosure of interest form]
* US FDA financial disclosure report – Executive Branch
* US FDA financial disclosure report – Executive Branch
* US FDA financial disclosure report – Special Government Employees
* US FDA financial disclosure report – Special Government Employees
Line 40:
Line 40:
* United States Preventive Services Task Force (USPSTF) disclosure of interest form
* United States Preventive Services Task Force (USPSTF) disclosure of interest form
−
=== Example algorithms/process maps for COI management ===
+
=== Examples of algorithms/process maps for COI management ===
* American Thoracic Society COI resolution procedure
* American Thoracic Society COI resolution procedure
* CADTH pan-Canadian Oncology Drug Review COI management overview (Appendix A)
* CADTH pan-Canadian Oncology Drug Review COI management overview (Appendix A)
Line 48:
Line 48:
* National Institute of Health and Care Excellence (UK) process for declaring interests (Appendix A)
* National Institute of Health and Care Excellence (UK) process for declaring interests (Appendix A)
−
=== Example of published summaries of disclosures ===
+
=== Examples of published summaries of disclosures ===
o Australian Technical Advisory Group on Immunisation disclosure summary
o Australian Technical Advisory Group on Immunisation disclosure summary
o Haute Authorité de Santé (France) examples of public disclosures of experts
o Haute Authorité de Santé (France) examples of public disclosures of experts
−
=== Example scales for assessing significance of COI ===
+
=== Examples of scales for assessing the significance of COI ===
o American Thoracic Society method for evaluating significance of COI
o American Thoracic Society method for evaluating significance of COI
Line 60:
Line 60:
o USPSTF COI significance and management table
o USPSTF COI significance and management table
−
=== GIN principles paper ===
+
=== [https://annals.org/aim/fullarticle/2450219/guidelines-international-network-principles-disclosure-interests-management-conflicts-guidelines GIN principles paper] ===
== References ==
== References ==
<references />
<references />